Elevance Health, Inc. (ELV)

Market Cap	78.59B
Revenue (ttm)	183.12B
Net Income (ttm)	5.92B
Shares Out	225.93M
EPS (ttm)	25.60
PE Ratio	13.59
Forward PE	9.83
Dividend	$6.84 (1.97%)
Ex-Dividend Date	Jun 10, 2025

Volume	2,006,212
Open	355.01
Previous Close	350.25
Day's Range	347.21 - 357.24
52-Week Range	347.21 - 567.26
Beta	0.61
Analysts	Strong Buy
Price Target	512.36 (+47.3%)
Earnings Date	Jul 17, 2025

About ELV

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a...

• Industry: Healthcare Plans
• Sector: Healthcare
• Founded: 1944
• Employees: 104,200
• Stock Exchange: NYSE
• Ticker Symbol: ELV
• Website: https://www.elevancehealth.com

Financial Performance

In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.

Analyst Summary

According to 14 analysts, the average rating for ELV stock is "Strong Buy." The 12-month stock price target is $512.36, which is an increase of 47.30% from the latest price.

Price Target

$512.36

(47.30% upside)

Analyst Consensus: Strong Buy